How To Increase Your Testosterone Levels Naturally | Derek from MPMD

The speaker outlines critical best practices for accurately measuring testosterone. He stresses that total testosterone reflects overall production, while free testosterone (typically 2-3% of total) is the biologically active form. Both are important. Measurements should ideally be taken early in the morning due to testosterone's pulsatile, diurnal rhythm, where levels are highest. Patients should be fasted and well-hydrated, and avoid biotin supplements, which can cross-react with assays and lead to inaccurate results. Crucially, he advises against making any treatment decisions based on a single reading, as levels can vary significantly. Repeat measurements, combined with a thorough assessment of symptoms, are essential to confirm low levels and determine the appropriate path forward, whether natural interventions or hormone therapy.

The speaker highlights the critical role of a balanced diet in supporting natural testosterone production. He explains that adequate fat intake is essential because cholesterol, derived from dietary fats, serves as the foundational substrate for all steroid hormones, including testosterone. Carbohydrates are also crucial, not just for energy, but because insulinogenic signaling helps suppress Sex Hormone Binding Globulin (SHBG), ensuring more free, active testosterone is available. Without sufficient carbohydrates, SHBG can rise, reducing free testosterone. Finally, adequate protein intake is vital for muscle repair and growth, which in turn improves body composition and overall hormonal health. He cautions against extreme dietary approaches that eliminate entire macronutrient groups, as these can inadvertently hinder hormone production and availability.

The speaker identifies resistance training as the most effective form of exercise for naturally boosting testosterone. He places it at the top of a hierarchy of exercise intensity, above HIIT and general movement, due to its direct impact on muscle and bone building, processes heavily reliant on testosterone. However, he emphasizes that 'adherence almost trumps optimal' – meaning that the best exercise is one that an individual can consistently stick to, rather than a theoretically perfect but unsustainable regimen. He also reiterates the caution against excessive training combined with inadequate fueling, which can lead to a state of malnourishment and subsequent hormone deficiency, as seen in extreme dieting for bodybuilding or endurance events.

The speaker outlines the scenarios in which Testosterone Replacement Therapy (TRT) becomes a viable option for men. He stresses that it should be considered only after exhausting all natural interventions, such as optimizing diet, exercise, sleep, and addressing micronutrient deficiencies. TRT is most clearly indicated for primary hypogonadism, where the testes themselves are unable to produce testosterone, or for secondary hypogonadism where the pituitary signal is insufficient, and the testes do not respond to stimulation (e.g., with hCG). He emphasizes the importance of ruling out structural defects (like varicocele) and pituitary issues before starting TRT. While TRT can dramatically improve symptoms and quality of life, it's crucial to manage expectations; it aims for symptom relief and physiological restoration, not necessarily a return to youthful vigor or supra-physiological levels. He strongly advises against self-medication or relying on clinics that offer haphazard protocols, advocating for informed decision-making with a knowledgeable medical professional.

The speaker discusses various methods for administering TRT, emphasizing that the ideal choice balances stable hormone levels, patient adherence, and risk mitigation. He strongly advises against pellets and generally discourages Androgel for men due to its limited efficacy in achieving optimal levels. Scrotal cream is presented as a highly effective option, providing excellent absorption and a pharmacokinetic profile that closely mimics natural pulsatile secretion, while also facilitating local 5-alpha reduction. However, it requires daily application and carries a risk of transference. Injections are the most common method, but infrequent dosing (e.g., once a week) can lead to supra-physiological peaks and troughs, increasing side effects. More frequent subcutaneous micro-injections (e.g., every other day) are recommended for maintaining stable levels. Newer oral testosterone undeanoate formulations offer convenience but are expensive and still being evaluated. He warns against the common practice of infrequent, high-dose injections, which can lead to significant fluctuations and heightened risks, and stresses that adherence should not compromise safety.

The speaker explains that exogenous testosterone, even at replacement doses, will significantly suppress a man's natural fertility, often leading to testicular atrophy and azoospermia (absence of sperm). This occurs because the brain perceives sufficient testosterone and estrogen, shutting down the hypothalamic-pituitary-gonadal (HPG) axis, which normally signals the testes to produce testosterone and sperm. To preserve fertility while on TRT, men must use adjunct therapies like Human Chorionic Gonadotropin (hCG) and recombinant Follicle-Stimulating Hormone (FSH). hCG mimics LH, stimulating the Leydig cells to produce intratesticular testosterone, which is crucial for spermatogenesis. Recombinant FSH directly supports Sertoli cells, also vital for sperm production. This approach allows for the maintenance of testicular size, function, and sperm production, but it is costly and requires careful monitoring, as it adds to the overall hormone load and can influence estrogen levels. He warns against relying on the misconception that high exogenous testosterone alone can maintain fertility, citing anecdotal cases in bodybuilding where accidental pregnancies occur despite suppression, but emphasizing that this is not a reliable method of contraception or fertility preservation.

The speaker stresses the critical importance of comprehensive biomarker monitoring for anyone on Testosterone Replacement Therapy (TRT). He outlines a broad panel of tests, starting with hematology (red blood cell count, hematocrit, hemoglobin) to watch for polycythemia. Metabolic parameters like fasting insulin and HbA1c are important to track overall metabolic health and insulin sensitivity, which can improve with TRT. A lipid panel, especially HDL, should be monitored as testosterone can suppress it. Hormone levels are paramount: total and free testosterone, estradiol (with sensitive assays like LCMS), LH and FSH (which should be suppressed on TRT), and SHBG (which will be suppressed by exogenous androgens). He also recommends advanced kidney function markers like cystatin C or SDMA/ADMA, as creatinine can be misleading in muscular individuals. A baseline assessment before starting TRT is non-negotiable, as it provides a reference point to evaluate the impact of therapy and identify any issues. He also mentions monitoring clotting risk factors and LP(a), noting that androgens can suppress LP(a), potentially masking a genetic predisposition.

The speaker asserts that the most effective strategy for preventing androgenic alopecia is to inhibit DHT, the primary androgen responsible for hair follicle miniaturization. He explains that the scalp's high concentration of 5-alpha reductase leads to significant local DHT conversion, which progressively weakens hair follicles. Pharmaceutical options like finasteride (inhibits two 5-alpha reductase isoenzymes) and dutasteride (inhibits all three, leading to near-complete systemic DHT suppression) are the most potent interventions. He acknowledges the controversial nature and potential side effects (e.g., sexual dysfunction, mood changes) associated with these drugs but argues that their prevalence is often exaggerated by media, while the benefits for preventing hair loss are substantial. He emphasizes that minoxidil, while effective for stimulating hair growth, does not address the underlying DHT-mediated miniaturization and thus cannot prevent progressive hair loss on its own. Early intervention is crucial, as prolonged hair loss can lead to irreversible fibrosis of the scalp.

The speaker acknowledges the widespread concern about declining male testosterone levels. While environmental factors like pollution and endocrine-disrupting chemicals are present and can have an effect, he emphasizes that their impact is often exaggerated compared to fundamental lifestyle choices. He suggests that the most significant contributors to this decline are obesity, poor diet, lack of exercise, and inadequate sleep. He also notes that comparing historical testosterone levels is complicated by differences in testing methodologies, making direct comparisons difficult. However, he firmly believes a downward trend exists, and addressing core lifestyle issues is paramount before focusing on more minute environmental concerns.

The speaker explains that while total testosterone might appear normal or even high on a ketogenic diet, the lack of insulin signaling inherent in such a diet can lead to a substantial increase in Sex Hormone Binding Globulin (SHBG). SHBG binds to testosterone, making it biologically inactive. Therefore, even with adequate total testosterone production, the amount of 'free' or usable testosterone can be significantly reduced, potentially leading to symptoms of low testosterone. He notes that this is why some individuals on carnivore diets, for example, have started incorporating fruit, to reintroduce some insulinogenic signaling and help manage SHBG levels. This mechanism is also relevant for women, as they have lower baseline androgen levels, making them more susceptible to the effects of elevated SHBG.

The speaker offers a speculative take on dutasteride's potential longevity benefits, suggesting that by profoundly inhibiting DHT, the most androgenic hormone, it could reduce overall androgenic stimulation. He posits that this reduction might mitigate potential negative effects associated with higher androgen levels, such as cardiotoxicity or excitotoxicity, particularly for individuals on Testosterone Replacement Therapy (TRT) who aim for high-normal testosterone levels. He notes that dutasteride has no impact on muscle growth, as DHT is not anabolic in adult muscle tissue. Furthermore, he highlights that dutasteride leads to a proportional increase in intra-tissue estrogen due to the inhibition of the 5-alpha reductase enzyme, which he believes could offer pro-longevity benefits like vasodilation and antioxidant effects. He acknowledges this is speculative and not scientifically proven but finds the idea intriguing for future research.

The speaker explains that male pattern hair loss, or androgenic alopecia, is fundamentally caused by the miniaturization of hair follicles due to androgens, primarily dihydrotestosterone (DHT). The scalp has a high density of 5-alpha reductase, the enzyme that converts testosterone to DHT, leading to a disproportionately high local concentration of DHT. This DHT activity shortens the hair's growth phase, causing follicles to produce progressively thinner and weaker hairs until they eventually cease production and the area undergoes fibrosis, making regrowth impossible. He stresses that treatments like minoxidil, while effective growth stimulants, do not prevent this miniaturization process. Therefore, to truly prevent hair loss, one must inhibit DHT, typically through pharmaceutical means like finasteride or dutasteride. He cautions against relying on anecdotal remedies or unproven methods, as delaying effective treatment can lead to irreversible damage.